Allworth Financial
PRME icon

Allworth Financial’s Prime Medicine PRME Stock Holding History

Allworth Financial’s Portfolio PRME Stock Details PRME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.72K Sell
1,278
-3,127
-71% -$10.4K ﹤0.01% 4146
2026
Q1 		$15.3K Buy
4,405
+1,290
+41% +$4.91K ﹤0.01% 3184
2025
Q4 		$10.8K Buy
3,115
+2,109
+210% +$9.38K ﹤0.01% 3220
2025
Q3 		$5.57K Buy
+1,006
New +$4.09K ﹤0.01% 3491
2025
Q1 		– Sell
-141
Closed -$449 – 4152
2024
Q4 		$449 Buy
+141
New +$495 ﹤0.01% 3629

Other funds holding PRME

Alphabet Inc
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ARK Investment Management
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
Woodline Partners
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Allworth Financial's PRME Position: Q2 2026 in Review

Allworth Financial reduced its Prime Medicine (PRME) stake by 71% in Q2 2026, selling an estimated $10.4K and leaving 1,278 shares worth $4.72K. The position accounts for ﹤0.01% of the portfolio, ranked #4146.

Allworth Financial first reported a position in PRME in Q4 2024 and has held it in 5 quarters since. The position peaked at $15.3K in Q1 2026. 187 funds tracked by Wall St. Rank hold PRME as of Q2 2026.

  • Allworth Financial held 1,278 shares of Prime Medicine worth $4.72K as of Q2 2026.
  • Allworth Financial sold 3,127 Prime Medicine shares in Q2 2026, an estimated $10.4K.
  • Prime Medicine made up ﹤0.01% of Allworth Financial's portfolio in Q2 2026, its #4146 holding.
  • Allworth Financial first reported a position in Prime Medicine in Q4 2024 and has held it in 5 quarters since.
  • Allworth Financial's Prime Medicine position peaked at $15.3K in Q1 2026.
  • 187 funds tracked by Wall St. Rank held Prime Medicine as of Q2 2026.

Based on Allworth Financial's 13F filing for Q2 2026, filed 11 Aug 2026.